Alternative content

Formed in 2008 by joining two innovative companies, MEDRAD Interventional / Possis is a provider of medical technologies designed for interventional cardiovascular procedures. MEDRAD's leadership began in 1965 with the first flow-controlled angiographic injector. Possis pioneered the leading technology to remove intra-vascular blood clots (thrombus) in 1997. Together, MEDRAD Interventional / Possis serves healthcare professionals and patients around the world with cutting-edge medical technology that helps make interventional procedures quicker, safer, and more effective.

Product Finder

MEDRAD Interventional / Possis Products

Our product lines include thrombectomy and contrast injection systems.

AngioJet® Ultra - the industry leading device for the mechanical removal of blood clots
Avanta™ - an advanced contrast injection system to illuminate blood vessels during interventional procedures
Fetch® Aspiration Catheter - a rapid exchange catheter approved for the removal of fresh, soft emboli and thrombi
GuardDOG® Occlusion System - provides the option of infusing and holding therapeutic or diagnostic fluid at the treatment site
SafeSeal® Hemostasis Patch - accelerates wound closure
Mark V ProVis® Injection System - MEDRAD’s most advanced angiographic injection system

Therapies & Diseases

For interventional therapy and disease information, you can learn more about a procedure called:

Thrombectomy

With manufacturing facilities in both Minneapolis, MN and Pittsburgh, PA, MEDRAD Interventional/Possis manufactures and markets segment-leading medical devices such as AngioJet® Thrombectomy Systems, MEDRAD Avanta™ Fluid Management Injector Systems, Mark V ProVis® Angiographic Contrast Injectors, FETCH® Aspiration Catheters and the SafeSeal® Hemostasis Patch.

Alternative content

MEDRAD Interventional / Possis Products

Therapies & Diseases

Press Releases

Upcoming Events